SITC Archive Library

iSBTc 21st Annual Meeting 

02-19-2018 14:18

The International Society for Biological Therapy of Cancer (iSBTc) 21st Annual Meeting
October 26-29, 2006
Hyatt Regency Century Plaza in Los Angeles, California

Program Organizers
Andrew Allen, MD, PhD - Pharmion Corporation
William E. Carson, III, MD - Ohio State University
Patrick Hwu, MD - MD Anderson Cancer Center

Program Summary
The 21st Annual Meeting consists of lectures and/or oral and poster presentations featuring the latest developments in a wide range of immunologic and biologic categories. These categories include adoptive therapy, angiogenesis, antibodies, cytokines, dendritic cells/vaccines, gene/nucleotide therapy, immune monitoring, immunoregulation/costimulation, new agents in targeted therapies, TLR/innate immunity, and the tumor microenvironment.

Intended Audience
The target audience for these programs incorporates basic and clinical investigators from academic, regulatory and biopharmaceutical venues. The audience includes clinicians, researchers, students, post-doctoral fellows and allied health professionals.

Presentations and video recordings are available based on permission from presenters.


#Biomarkers #ClinicalTrials #BreastCancers #PresentationSlides #AnnualMeeting #AdverseEvents #Toxicities #AdoptiveCellTherapy #Cytokines #TherapeuticAntibodies #Vaccines #Clinician #Oncologist #AlliedHealth #Researcher #2006​​​​​​​​ #HeadandNeckCancers #Leukemia #Lymphoma #Melanoma #Non-SmallCellLungCancer
#OvarianCancer #SITC

Statistics
0 Favorited
19 Views
15 Files
0 Shares
32 Downloads
Attachment(s)
pdf file
Targeting Tumor Antigen Delivery to Dendritic Cells In Vivo   2.71 MB   1 version
Uploaded - 02-19-2018
Meeting: iSBTc 21st Annual Meeting; Presentation: Targeting Tumor Antigen Delivery to Dendritic Cells In Vivo; Presenter: Larry Kwak, MD, PhD - MD Anderson Cancer Center; Date: Friday, October 27, 2006
pdf file
II Trial   374 KB   1 version
Uploaded - 02-19-2018
Meeting: iSBTc 21st Annual Meeting; Presentation: Immunogenicity and Clinical Efficacy of a Hi-8TM PrimeBoost Therapeutic Vaccine in Stage III/IV Melanoma Patients in a Phase I/II Trial; Presenter: Richard J. Anderson, PhD - Oxxon Therapeutics Limited; Date: Friday, October 27, 2006
pdf file
A Phase I Trial of a Monoclonal Antibody to OX40 in Patie...   1.80 MB   1 version
Uploaded - 02-19-2018
Meeting: iSBTc 21st Annual Meeting; Presentation: A Phase I Trial of a Monoclonal Antibody to OX40 in Patients with Advanced Cancer; Presenter: Brendan D. Curti, MD - Earle A. Chiles Research Institute; Date: Friday, October 27, 2006
pdf file
A Histone Deacetylase Inhibitor (HDACi) Sensitizes B16 Me...   401 KB   1 version
Uploaded - 02-19-2018
Meeting: iSBTc 21st Annual Meeting; Presentation: A Histone Deacetylase Inhibitor (HDACi) Sensitizes B16 Melanoma to Adoptive Transfer (AT) Immunotherapy; Presenter: Dan Vo - University of California, Los Angeles; Date: Friday, October 27, 2006
pdf file
Preclinical Studies of IL-21 Plus Rituximab Combination T...   481 KB   1 version
Uploaded - 02-19-2018
Meeting: iSBTc 21st Annual Meeting; Presentation: Preclinical Studies of IL-21 Plus Rituximab Combination Therapy for B-Cell Lymphoma; Presenter: Wayne Kindsvogel, PhD - ZymoGenetics, Inc.; Date: Friday, October 27, 2006
pdf file
Effects of rhlL7 Administration in Humans Results in Pref...   2.24 MB   1 version
Uploaded - 02-19-2018
Meeting: iSBTc 21st Annual Meeting; Presentation: Effects of rhlL7 Administration in Humans Results in Preferential Expansion of Naive, and Memory Subsets of CD4+ and CD8+ T Cells; Presenter: Claude Sportés, MD - National Cancer Institute; Date: Friday, October 27, 2006
pdf file
Results from the Immunologic Monitoring Consortium   376 KB   1 version
Uploaded - 02-19-2018
Meeting: iSBTc 21st Annual Meeting; Presentation: Evaluation of the Performance of Immunologic Monitoring Assays: Results from the Immunologic Monitoring Consortium; Presenter: Mary L. Disis, MD - University of Washington; Date: Friday, October 27, 2006
pdf file
The Paradoxical Effect of High Dose Interleukin-2 (IL-2) ...   706 KB   1 version
Uploaded - 02-19-2018
Meeting: iSBTc 21st Annual Meeting; Presentation: The Paradoxical Effect of High Dose Interleukin-2 (IL-2) on CD4+CD25+ Regulatory T Cells; Presenter: Howard F. Kaufman, MD - Columbia University; Date: Saturday, October 28, 2006
pdf file
Maintenance of CD27+ Effector Memory T Cells During Ex Vi...   622 KB   1 version
Uploaded - 02-19-2018
Meeting: iSBTc 21st Annual Meeting; Presentation: Maintenance of CD27+ Effector Memory T Cells During Ex Vivo Expansion of Melanoma TIL is Critical for Adoptive T Cell Therapy; Presenter: Yufeng Li - MD Anderson Cancer Center; Date: Saturday, October 28, 2006
pdf file
Induction of Anti-Tumor Immunity by Anti-Tumor Monclonal ...   580 KB   1 version
Uploaded - 02-19-2018
Meeting: iSBTc 21st Annual Meeting; Presentation: Induction of Anti-Tumor Immunity by Anti-Tumor Monclonal Antibodies; Presenter: Madhav Dhodapkar, MD - The Rockefeller University; Date: Saturday, October 28, 2006
pdf file
Results of InVivo Tumor Cell Killing and Therapeutic Vac...   496 KB   1 version
Uploaded - 02-19-2018
Meeting: iSBTc 21st Annual Meeting; Presentation: Immunotherapy with Antibody Targeted MHC Complexes: Results of InVivo Tumor Cell Killing and Therapeutic Vaccination; Presenter: Philip M. Savage, PhD, FRCP - Charing Cross Hospital; Date: Saturday, October 28, 2006
pdf file
CD8 T Cell-Mediated Antitumor Effect on Imiquimod in a Mo...   221 KB   1 version
Uploaded - 02-19-2018
Meeting: iSBTc 21st Annual Meeting; Presentation: CD8 T Cell-Mediated Antitumor Effect on Imiquimod in a Mouse Model of Breast Cancer; Presenter: Antoni Ribas, MD - University of California, Los Angeles Medical Center; Date: Saturday, October 28, 2006
pdf file
Changes in Intratumoral Immune Cell Infiltrates, Foxp3 an...   2.33 MB   1 version
Uploaded - 02-19-2018
Meeting: iSBTc 21st Annual Meeting; Presentation: Changes in Intratumoral Immune Cell Infiltrates, Foxp3 and Indoleamine 2, 3-dioxygenase (IDO) Expression with the CTLA4 Blocking mAb CP-675,206; Presenter: Hailing Lu, PhD - University of Washington; Date: Saturday, October 28, 2006
pdf file
Tumor Microenviroment Immune Responses Associated with t...   373 KB   1 version
Uploaded - 02-19-2018
Meeting: iSBTc 21st Annual Meeting; Presentation: Poster Discussion Session: Tumor Microenviroment Immune Responses Associated with the Progression of Cancer; Presenter: Stephen Hodi, MD - Dana-Farber Cancer Institute; Date: Saturday, October 28, 2006
pdf file
Early and Late Clinical Vaccine Development   159 KB   1 version
Uploaded - 02-19-2018
Meeting: iSBTc 21st Annual Meeting; Presentation: 2005 Workshop Update: Early and Late Clinical Vaccine Development; Presenter: Axel Hoos, Md, PhD - Bristol-Myers Squibb Company; Date: Sunday, October 29, 2006